Related Experiment Video

Updated: May 17, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

Metabolic profiling: are we en route to better diagnostic tests for cancer?

Haiwei Gu, G A Nagana Gowda, Daniel Raftery

    Future Oncology (London, England)
    |November 8, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
    06:51

    Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

    Published on: July 21, 2018

    On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis
    06:48

    On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

    Published on: May 31, 2020

    Related Experiment Videos

    Last Updated: May 17, 2026

    Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
    08:08

    Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

    Published on: February 27, 2015

    Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
    06:51

    Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

    Published on: July 21, 2018

    On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis
    06:48

    On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

    Published on: May 31, 2020

    Related Concept Videos

    Serum Laboratory Studies, Stool Test, Breath Test01:30

    Serum Laboratory Studies, Stool Test, Breath Test

    Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...

    Articles linked to this work by shared authors, journal, and citation graph.

    Serum-based biomarker development for dietary macronutrient densities and their association with breast and colorectal cancer risk in a cohort of postmenopausal females.

    The American journal of clinical nutrition·2026

    An Observational Study of Vaginal Antibacterial Activity and Outcomes after Antibiotic Prescription for Bacterial Vaginosis.

    The Journal of infectious diseases·2026

    Biomarker-calibrated dietary macronutrient densities and their comparative associations with chronic disease risk in a cohort of postmenopausal females.

    The American journal of clinical nutrition·2026

    Acute gastrointestinal graft-versus-host disease is associated with reductions of secondary bile acids following allogeneic hematopoietic cell transplantation.

    Frontiers in microbiology·2026

    Metabolome remodeling with reverse-engineered exclusive enteral nutrition in children with active Crohn's disease.

    Inflammatory bowel diseases·2026

    Metabolomic signatures of dietary carbohydrates and differential association with type 2 diabetes.

    Nature health·2026

    A phase II study assessing the feasibility and clinical efficacy of adaptive immunotherapy combination with VEGFR-TKI in patients with advanced renal cell carcinoma.

    Future oncology (London, England)·2026

    Persistence and adherence to tepotinib in patients with metastatic non-small cell lung cancer: a real-world evidence study including dose reductions.

    Future oncology (London, England)·2026

    DESTINY-Lung06: trastuzumab deruxtecan and pembrolizumab as first-line treatment for HER2-overexpressing, PD-L1 TPS <50% NSCLC.

    Future oncology (London, England)·2026

    The ongoing first-line treatment race for metastatic pancreatic ductal adenocarcinomas: will a tough disease lose its horror?

    Future oncology (London, England)·2026

    Study protocol on quality of life and erectile function recovery in unfavorable intermediate-risk prostate cancer: REDI-CaP trial.

    Future oncology (London, England)·2026

    PSMA-PET/mpMRI-guided focal dose-escalated stereotactic body radiotherapy for localized prostate cancer: study protocol for a prospective, randomized controlled trial.

    Future oncology (London, England)·2026

    Lactate-induced epithelial-mesenchymal transition: a metabolic nexus in pancreatic cancer metastasis.

    Translational cancer research·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us